Bispecific anti-CD20/anti-CD3 antibodies to treat acute lymphoblastic leukemia

• 收藏
• 分享

专利权人:

Inc.;Regeneron Pharmaceuticals

发明人:

Brownstein, Carrie

申请号：

AU2016378573

公开号：

AU2016378573A1

申请日:

2016.12.21

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

The present invention provides methods for treating, reducing the severity, or inhibiting the growth of acute lymphoblastic leukemia. The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a bispecific antibody that specifically binds to CD20 and CD3.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/